Codes / ICD10CM / L30.5

L30.5 Pityriasis alba

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Pityriasis alba

Summary

Pityriasis alba is a common, benign skin condition characterized by hypopigmented (lighter than surrounding skin) patches, often with fine scaling. It primarily affects children and young adults, typically on the face, neck, or arms. The patches are usually asymptomatic but may appear slightly dry or scaly. The condition is self-limiting and resolves over time without scarring.

Causes

The exact cause is not fully understood, but it is thought to involve mild inflammation or eczematous changes, possibly triggered by dry skin, sun exposure, or environmental factors. It may represent a mild form of atopic dermatitis or post-inflammatory hypopigmentation. Documentation should note the absence of significant inflammation or infection.

Risk Factors

  • Dry or sensitive skin.
  • Atopic predisposition (e.g., history of eczema, asthma, or allergies).
  • Sun exposure, which can accentuate hypopigmentation.
  • Young age, particularly children and adolescents.
  • Environmental irritants or seasonal changes.

Symptoms

  • Hypopigmented patches (pale, light-colored) on the face, neck, or arms.
  • Fine, barely perceptible scaling on the patches.
  • No significant itching, pain, or discomfort.
  • Patches may appear slightly rough or dry to the touch.

Diagnosis

Diagnosis is primarily clinical, based on the characteristic appearance of hypopigmented patches with minimal scaling. A healthcare provider may examine the skin and review the patient’s history. No specific tests are typically required, as the condition is benign and self-resolving. Differential diagnosis may include tinea versicolor or vitiligo, but pityriasis alba lacks the distinct features of these conditions.

Treatment Options

  • Gentle moisturizers to soothe dryness and support the skin barrier.
  • Low-potency topical corticosteroids (short-term) to reduce mild inflammation.
  • Sun protection (e.g., sunscreen) to prevent further hypopigmentation.
  • Avoidance of harsh soaps or irritants that may exacerbate dryness.

Prognosis and Follow-Up

The condition is self-limiting and typically resolves within months to a few years without scarring. Follow-up is generally not required unless symptoms worsen or the diagnosis is uncertain. Reassurance about the benign nature of the condition is often sufficient.

Complications

  • Temporary cosmetic concern due to hypopigmentation.
  • Rarely, mild scaling or dryness may persist temporarily.
  • No long-term complications or systemic involvement.

Lifestyle & Prevention

  • Maintain skin hydration with gentle, fragrance-free moisturizers.
  • Use sunscreen to protect affected areas from sun exposure.
  • Avoid harsh soaps, hot water, or excessive scrubbing.
  • Manage underlying atopic conditions (e.g., eczema) to reduce flare-ups.

When to Seek Professional Help

  • If patches become inflamed, itchy, or painful.
  • If the diagnosis is unclear or other conditions (e.g., fungal infection) are suspected.
  • If hypopigmentation worsens or does not improve over time.

Tips for Medical Coders

Document the presence of hypopigmented patches with fine scaling, typical locations (face, neck, arms), and the patient’s age. Note the absence of significant inflammation, infection, or other systemic symptoms. Ensure documentation supports the benign, self-limiting nature of the condition to justify the use of L30.5.

Book a walkthrough

L30.5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.